Passage Bio Inc
NASDAQ:PASG
Passage Bio Inc
NASDAQ:PASG
Price:
3.52
USD
5.71%
Market Closed
Market Cap:
$11.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
M
|
MTU Aero Engines AG
XMUN:MTX
|
DE |
|
Black Hills Corp
F:BHI
|
US |
|
A
|
Agilysys Inc
F:PS3
|
US |
|
A
|
Amerisafe Inc
F:A3I
|
US |
|
Newfoundland Discovery Corp
F:M4K
|
CA |
Intrinsic Value
Not Available for PASG
There is not enough data to reliably calculate the intrinsic value for Passage Bio Inc.
Do our valuations actually work? See backtest results .
Alternatives to PASG
Fundamental Analysis
What Passage Bio Does
Passage Bio is a biotechnology company that develops gene therapies for rare genetic diseases, especially disorders that affect the brain and nervous system. Its main work is to design treatments that replace or repair faulty genes, with a focus on diseases that have few or no good treatment options.
- Headquarters
- United States of America US
- Employees
- 24
- IPO date
- Feb 28, 2020
Financials
Efficiency
Earnings Waterfall
Passage Bio Inc
Passage Bio Inc
